Pfizer recalls 2 lots of migraine drug RELPAX over possible microbial contamination Farhat Nasim17 Aug 2019 3:44 AM GMTLots of Pfizer Inc's Relpax were distributed nationwide to wholesalers, retailers, hospitals and healthcare providers in the 50 states and Puerto Rico...
DOP junks Geltec plea against NPPA decision on retail price of Ibuprofen Soft Gelatin Capsules Farhat Nasim28 July 2019 6:00 AM GMTNew Delhi: Through a recent decision, the Department of Pharmaceuticals (DOP) has rejected the review application filed by Geltec Private Limited...
Dr Reddys to sell Tosymra, Zembrace to Upsher-Smith Labs for Rs 765 crore approx Farhat Nasim15 Jun 2019 4:30 AM GMTDr Reddy's (Dr Reddys) Labs said Tosymra and Zembrace were designed and developed with the goal of addressing unmet needs of large but discrete...
Eli Lilly to present new data on Emgality, Lasmiditan at AAN annual meeting Farhat Nasim5 May 2019 4:30 AM GMTEmgality is also currently under Priority Review by the FDA as an investigational drug for the preventive treatment of episodic cluster headache in...
USFDA accepts Allergan license applications to expand Botox label Farhat Nasim11 March 2019 4:00 AM GMT"The FDA's acceptance of Allergan's supplemental biologics license applications is a monumental milestone on our journey to bring new treatment...
